MYD88 and autoimmune polyendocrinopathy: To further analyze whether TLR4 and MyD88 are involved in APS-induced macrophage activation, cells were pre-treated with TAK-242 and ST2825, which are inhibitors of TLR4 and MyD88, respectively.